Frequency of Piriformis Syndrome:Does the Presence of One Pathology Rule Out the Other?

NCT05450913 | Unknown

• 1 other identifier: piriformis
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

The purpose of the investigators is to determine the frequency of priformis syndrome in patients presenting with hip and/or leg pain and to investigate the association of Priformis syndrome with other pathologies of the lumbar spine and hip.

Conditions

Chronic Pain

Keywords

piriformis syndrome; myofascial pain; ultrasound guidance; trigger point injection

Outcome Measures

Primary Outcomes (1)

• To determine the frequency of Priformis syndrome

  Change in Pain Scores on Visual Analogue Scale scores at 24 hours before and after Priformis muscule injection

  1 months

Study Arms (1)

patients with unilateral hip and leg pain

OTHER

Musculoskeletal system examination, neurological examination, visual analog scale (VAS) score and DN4 (Douleur Neuropathique 4 Questions) of patients presenting with unilateral hip and/or leg pain, 3 tests frequently used in the diagnosis of priformis (Freiberg test, Pace sign, FADIR) ) will be applied. Patients with suspected priformis syndrome will be given an intramuscular injection If the pain intensity decreases by 50% or more after the intramuscular injection, the diagnosis of piriformis will be made.

Drug: Priformis intramuscular injection with %2 lidocain

Interventions

Priformis intramuscular injection with %2 lidocain DRUG

Priformis intramuscular injection will be administered with 5 cc 2% lidocaine, accompanied by a nerve stimulator under ultrasound guidance

Also known as: pyriformis intramuscular injection or diagnostic test with local anesthetic

patients with unilateral hip and leg pain

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients presenting with unilateral hip and/or leg pain

Sponsors & Collaborators

• Diskapi Teaching and Research Hospital: lead

MeSH Terms

Conditions

Chronic Pain; Piriformis Muscle Syndrome

Interventions

Anesthetics, Local

Condition Hierarchy (Ancestors)

Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Sciatic Neuropathy; Mononeuropathies; Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Nerve Compression Syndromes; Neuralgia; Pelvic Pain

Intervention Hierarchy (Ancestors)

Anesthetics; Central Nervous System Depressants; Physiological Effects of Drugs; Pharmacologic Actions; Chemical Actions and Uses; Sensory System Agents; Peripheral Nervous System Agents; Central Nervous System Agents; Therapeutic Uses

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD

Study Record Dates

• First Submitted: March 21, 2022
• First Posted: July 11, 2022
• Study Start: July 10, 2022
• Primary Completion: July 15, 2022
• Study Completion: July 15, 2022
• Last Updated: July 12, 2022

Record last verified: 2022-07